Various lipids extracted from bovine thyroid glands were tested for their ability to affect the binding of -25I-labeled thyrotropin to bovine thyroid membranes. 
phospholipids. In addition, the mode of action of these two classes of acidic lipids was different. When thyroid membranes were preincubated with the phospholipids and then separated by centrifugation, their ability to bind thyrotropin was still diminished. In contrast, gangliosides appear to interact with the hormone and not with the membranes. The effect of phospholipids on thyroid membranes was further examined by incubating the membranes with phospholipase A. The treated membranes now bound more labeled hormone. These results suggest that certain acidic phospholipids, which are present in only small amounts in thyroid membranes, influence the state of the thyrotropin receptor and its ability to bind thyrotropin.
The initial event in thyrotropin (TSH)-mediated effects on thyroid cells is the binding of the hormone to specific receptors on the plasma membrane of the cells. Subsequently, a transmembrane signaling event occurs, which leads to the generation of a second messenger inside the cell. For TSH, this second messenger is cyclic AMP (1) , and transmembrane signaling causes the activation of adenylate cyclase by mechanisms not yet understood. Recently , it has been suggested that gangliosides are involved in this process (see ref.
2). Thus, gangliosides (3) and, in particular, gangliosides from thyroid tissue (4) inhibit the binding of TSH to thyroid membranes. There are certain structural similarities between TSH and cholera toxin (3, 5, 6 ).
The latter agent utilizes ganglioside GM, as its specific cell surface receptor (see ref.
2) and can activate adenylate cyclase in thyroid preparations (7, 8) . Furthermore, thyroid tumor cells that are deficient in gangliosides more complex than GM3 were unresponsive to TSH (9) .
On the other hand, an important role for phospholipids has been implicated in hormone-responsive adenylate cyclase systems (10) (11) (12) (13) (14) (15) . Treatment of thyroid slices and membranes with phospholipases profoundly depressed the stimulation of adenylate cyclase by TSH (10-13) but resulted in enhanced binding of TSH to membranes (13) (14) (15) . In order to explore further the relative roles of these two classes of acidic phospholipids on TSH action, we separated the various lipid classes from bovine thyroid glands and studied their ability to affect the binding of bovine TSH to bovine thyroid membranes.
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MATERIALS AND METHODS Materials. Highly purified bovine TSH was a generous gift from John Pierce (University of California at Los Angeles) and was iodinated by the chloramine-T procedure as described (16) ; the specific radioactivity of different preparations ranged from 38 to 71 ,uCi/,ug. Sigma was the source of the unlabeled TSH used in the binding assays as well as purified phospholipids and phospholipase A2 (bee venom, 1300 units/mg). Phospholipase C (Clostridium welchii, 6.6 units/mg) was obtained from Calbiochem.
Binding Assay. Plasma membranes from bovine thyroid glands were prepared as described by Wolff and Jones (17) , stored frozen in liquid nitrogen, and washed prior to use by suspending them in 25 mM Tris acetate buffer (pH 6.0) and centrifuging at 30,000 X g for 10 min (4). The standard binding assay was similar to that described elsewhere (4) and contained 125,000 cpm of 125I-labeled TSH (125I-TSH), 5og of membrane protein, 0.5% bovine serum albumin, and 25 mM Tris acetate buffer (pH 6.0) in a total volume of 100,l. Incubations were for 1 hr at 40C, and bound radioligand was separated from free 125I-TSH by filtration on cellulose acetate filters (4). Nonspecific binding was determined by incubating the membranes in the presence of an excess of unlabeled TSH (1.5 ,M). Specific binding of 5 ,ug of membranes was 20,000-25,000 cpm, a value that is on the upward slope of the binding curve when cpm bound is plotted against amount of membranes. Lipids to be tested in the binding assay were dried from chloroform/ methanol (2:1, vol/vol) under a stream of N2 and dispersed in 25 mM Tris acetate buffer (pH 6.0) by sonication for 10 min just prior to being assayed.
Extraction and Separation of Thyroid Lipids. Lipids were extracted from bovine thyroid glands and partitioned into upper and lower phases as described (4) . The upper-phase lipids were chromatographed on a DEAE-Sephadex column (18) and eluted stepwise with methanol, 0.25 M ammonium acetate in methanol, and 0.5 M ammonium acetate in methanol. The fractions containing gangliosides were combined, taken to dryness, dissolved in water, dialyzed, and lyophilized. To separate gangliosides from other acidic lipids, we used a slight modification of the method of Yu and Ledeen (18) . The lyophilized material was dissolved in chloroform/methanol (19:1, vol/vol) and applied to a Unisil column (200-325 mesh) that was eluted stepwise with increasing concentrations of methanol in chloroform as described in Table 1 . Any remaining phosAbbreviations: GM1, galactosyl-N-acetylgalacosaminyl-(N-acetylneuraminyl)galactosylglucosylceramide; GM3, N-acetylneuraminylgalactosylglucosylceramide; CL, cardiolipin; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; PtdGro, phosphatidylglycerol; PtdIns, phosphatidylinositol; PtdSer, phosphatidylserine; SM, sphingomyelin; TSH, thyrotropin; 125I-TSH, l25I-labeled TSH.
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pholipids were removed from the ganglioside fraction by saponification for 1 hr at 37°C in chloroform/0.6 M NaOH in methanol (2:1, vol/vol). The mixture was neutralized with 0.05 vol of 4 M acetic acid and desalted on Sephadex G-25 (19) .
Lower-phase lipids (corresponding to 100 g of tissue) were fractionated on a Unisil column (10 g) according to Vance and Sweeley (20) . The column was eluted with 150 ml of chloroform (fraction A), 300 ml of acetone/methanol (9:1, vol/vol) (fraction B), and 150 ml of methanol (fraction C). Fraction B was further purified on a DEAE-Sephadex column (1 g) that was eluted with 100 ml of chloroform/methanol/water (30: 60:8, vol/vol) (fraction B1) and 130 ml of chloroform/methanol/0.8 M sodium acetate (30:60:8, vol/vol) (fraction B2) (18) . Fraction B2 was desalted on Sephadex G-25 (19) and further separated by preparative thin-layer chromatography. After exposure of the chromatogram to iodine vapor, individual zones were scraped from the plate and eluted with chloroform/methanol/water (65:25:4, vol/vol) and chloroform/methanol (2:1, vol/vol) (refer to Fig. 2 for the fractionation scheme).
Other Methods. Thin-layer chromatography was carried out on silica gel 60 on glass plates (E. Merck). Gangliosides (21), phospholipids (22, 23) , and other lipids (24) (4), and membrane protein (26) were determined by established procedures. Membranes were treated with phospholipases as described by Pohl et al. (27) with minor modifications (12) .
RESULTS
Analysis of Upper-Phase Lipids from Bovine Thyroid. As reported (4) , the crude upper-phase lipids contained a complex mixture of gangliosides. In addition, there was a considerable amount of phospholipid (2 nmol/nmol of sialic acid). When the upper-phase lipids were chromatographed on Unisil, most of the gangliosides were recovered in fraction 3 and most of the phospholipids were in fraction 2 (Table 1) . Analysis by thinlayer chromatography indicated that fraction 1 contained cardiolipin (CL) and phosphatidylglycerol (PtdGro), fraction found to be more inhibitory (Fig. 1) . After saponification to destroy any remaining phospholipids, fraction 3 still inhibited the binding of TSH to membranes but was considerably less potent than the original upper phase; 50 nmol of lipid-bound sialic acid in fraction 3 after saponification caused 54% inhibition whereas 5 nmol in the original upper phase caused 57% inhibition. This latter value is similar to that reported previously (4) .
Analysis of Lower-Phase Lipids from Bovine Thyroid. When the lower phase lipids were fractionated on silicic acid and DEAE-Sephadex columns, the inhibitory activity was recovered in fraction B2 which contained the acidic phospholipids (Fig. 2 ). These were separated by preparative thin-layer chromatography and identified by two-dimensional chromatography as CL, PtdGro Ptdlns, and PtdSer. The first three of these were potent inhibitors of TSH binding and were as effective as highly purified phospholipids obtained commercially (Table 2) . Thus, the inhibitory effects observed with our preparations from bovine thyroid appear to be due to these phospholipids. CL was the most effective inhibitor; 1.3 nmol (2.6 nmol of phosphorus) caused 50% inhibition (Fig. 3) . This degree of inhibition was obtained with 4.6 nmol of PtdGro and 7.1 nmol of PtdIns; PtdSer was a weak inhibitor. The major phospholipids present in bovine thyroid were phosphatidylcholine (PtdCho), phosphatidylethanolamine (PtdEtn), and sphingomyelin (SM) ( Table 3 ). These phospholipids as wellas (Fig. 4) . Again CL was most effective, followed by PtdGro and PtdIns. The inhibition was selective: other phospholipids did not cause a loss in binding. Bovine thyroid membranes (2 mg of protein per ml) were incubated with the indicated concentration of phospholipase A in 1 assay, it appeared that the inhibitory effect of these phospholipids was due to their interaction with the membranes and not with the hormone.
We explored this effect further by incubating the membranes with phospholipases. In agreement with reports of others (13) (14) (15) , treatment of the membranes with phospholipase A resulted in an increase in TSH binding (Table 4) . When the membranes treated with phospholipase A were exposed to acidic phospholipids as described above, there was a dramatic decrease in TSH binding (data not shown). In contrast, we did not observe a similar effect with phospholipase C. When we incubated the membranes with and without phospholipase C under identical conditions at 370C, we observed a loss in TSH binding with both sets of membranes. Amir et al. (15) reported that incubation of bovine thyroid membranes at elevated temperatures caused a loss in TSH receptor sites. They also reported that phospholipase C treatment stimulated TSH binding (15) , whereas Haye and Jacquemin (14) found that phospholipase C caused an increase in TSH binding to 6ovine thyroid membranes at low but not high concentrations of
TSH. DISCUSSION
Of the various lipid classes isolated from bovine thyroid gland, we found that only two classes, gangliosides and acidic phospholipids, affected the interaction of TSH with thyroid plasma membranes. The inhibition of TSH binding by gangliosides has been described (3, 4), but it is apparent from our present work that some of the inhibition was due to the presence of phospholipids in the ganglioside preparations. Our results indicate that certain phospholipids alter the membrane components responsible for the binding of TSH. Only the highly polar, negatively charged phospholipids (CL, Ptdlns and PtdGro) were able to affect the interaction of the receptor with the hormone. Although CL was the most potent inhibitor, it is presumed to be a mitochondrial membrane component (32) and its presence in plasma membranes has not been described. PtdIns and PtdGro are plasma membrane components. A role for these phospholipids in influencing the ability of the TSH receptor to bind hormone is supported further by our experiments with phospholipase A. Treatment of thyroid membranes with this enzyme caused an increase in TSH binding and exposure of these treated membranes to the above phospholipids reduced TSH binding.
The effects of phospholipids on hormone-stimulated adenylate cyclase systems has been best examined with a glucagon-sensitive system (27, (33) (34) (35) . Levey and coworkers (33) observed that Lubrol PX-solubilized adenylate cyclase lost its sensitivity to glucagon and addition of phospholipids to the solubilized enzyme restored the hormone response. The phospholipid effect appeared to be specific because PtdSer but not PtdIns was active. Rodbell and collaborators (27, 34) found that phospholipase A treatment of liver membranes abolished the response of adenylate cyclase to glucagon and addition of membrane phospholipids restored hormone sensitivity. There were corresponding effects on the binding of glucagon to the membranes. Further studies with phospholipases of different specificities indicated that the enzymes that hydrolyzed acidic phospholipids were the most effective (35) .
The involvement of membrane phospholipids in the TSHstimulated adenylate cyclase system appears to be more complex. Treatment of thyroid membranes with phospholipase A or C caused a decrease in TSH-stimulated adenylate cyclase activity (10) (11) (12) (13) and subsequent addition of PtdChb or PtdSer partially restored hormone response (12) . In addition, membranes treated with Lubrol PX lost their TSH response, and addition of PtdCho partially restored hormone sensitive adenylate cyclase activity (12) . However, our results as well as reports of others (13) (14) (15) We can only speculate on how these acidic phospholipids modulate the ability of the receptor to bind TSH. Current concepts of membrane structure envision membrane receptors as asymmetric with their hydrophobic regions buried in the fluid lipid bilayer. In addition, membrane phospholipids may be distributed asymmetrically both laterally and transversely in the bilayer. Thus, the receptors may exist in local domains enriched in certain phospholipids, and the composition of these phospholipids surrounding the hydrophobic region of the receptor as it traverses the membrane may be different in the two halves of the bilayer. Small changes in phospholipid composition could have profound effects on local fluidity and charge in such domains. An increase in negative charge could lead to a local increase in cations such as Ca2+ which has been reported to inhibit TSH binding (13, 15) or to a repulsion of other negatively charged membrane components that are involved in hormone Proc. Natl. Acad. Sci. USA 75 (1978) 5305 binding. § Changes in fluidity could lead to a vertical displacement of the receptor (37) 
